期刊文献+

细胞块p16联合高危型HPV检测在ASCUS患者分流管理中的作用 被引量:7

Effect of high-risk human papilloma virus test combined with detection of p16 expression in cell blocks on triage of patients with atypical squamous cell of undetermined significance
下载PDF
导出
摘要 目的探讨细胞块p16联合高危型人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)检测在未明确意义的非典型鳞状上皮(atypical squamous cell of undetermined significance,ASCUS)患者分流管理中的作用。方法选取108例子宫颈液基细胞学诊断为ASCUS的病例,同时行HR-HPV杂交捕获法Ⅱ(hybrid capture2,HC2)检测及免疫组化p16染色,均行阴道镜下活检。结果 (1)p16表达率和HR-HPV检出率在炎症组、湿疣/CIN1、CIN2、CIN3组中分别为12.5%(6/48)和31.25%(15/48)、60.53%(23/38)和84.21%(21/38),84.62%(11/13)和92.31%(12/13)、100%(9/9)和100%(9/9),组间差异有统计学意义(P<0.001);湿疣/CIN1组与CIN2/3组间p16表达率分别为60.53%(23/38)、90.91%(20/22),差异有统计学意义(P<0.012 5)。(2)p16联合HR-HPV检测、单纯行p16和HR-HPV检测在ASCUS中分流子宫颈病变的敏感性和阴性预测值分别为98.33%(59/60)、71.67%(43/60)、88.33%(53/60),97.06%(33/34)、71.19%(42/59)、82.5%(33/40),差异均有统计学意义(P<0.05)。p16+/HC2+者高级别病变检出率(44.19%,19/43)与p16-/HC2+者(8%,2/25)比较差异有统计学意义(P<0.001)。结论 p16蛋白可以作为一种辅助诊断CIN的免疫组化标志物。细胞块p16联合HR-HPV检测可以有效分流ASCUS中的子宫颈病变患者。 Purpose To study the effect of high-risk human papillomavirus test combined with detection of p16 expression in cell blocks on triage of patients with atypical squamous cell of undetermined significance (ASCUS). Methods Selected 108 ASCUS cases were performed with HR-HPV test and p16 immunostaining in cell blocks, followed by colposcopy and cervical biopsy. Results The rates of p16 expression and HR-HPV infection in eervicitis, condyloma/CIN1, CIN2 and CIN3 of cervical biopsy were 12. 5 % (6/48) and 31.25% ( 15/48), 60. 53% (23/38) and 84. 21% (21/38), 84. 62% (11/13) and 92. 31% ( 12/13), and 100% (9/9) and 100% (9/9) , respectively, with significant difference (P 〈 0. 001 ). The rates of p16 expression in condyloma/CIN1 and CIN2/3 were 60. 53% (23/38), 90.91% (20/22) respectively, also with significant difference between them (P 〈 0. 012 5 ). The sensitivity and negative predictive values of p16 combined with HR-HPV, single p16 or HR-HPV were 98.33% (59/60) and 71.67% (43/ 60), 88.33% (53/60)and97.06% (33/34), and71.19% (42/59)and82. 5% (33/40), respectively, (P〈0.05). The detection rate of high grade lesion in p16 +/HR-HPV + and p16 -/HR-HPV + was 44. 19% (19/43) and 8% (2/25). respectively, ( P 〈 0. 001 ). Conclusion The immunostaining of p16 protein could contribute to diagnosis of CIN. HR-HPV test combined with p16 immunostaining in cell block could be help in the triage of patients with cervical lesions of ASCUS efficiently.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第8期868-870,875,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 浙江省医药卫生科技成果重点推广计划(2009TG008)
关键词 未明确意义的非典型鳞状上皮 细胞块 P16蛋白 人乳头瘤病毒 atypical squamous cell of undetermined significance cell blocks p16 protein human papilloma virus
  • 相关文献

参考文献8

二级参考文献60

共引文献34

同被引文献65

  • 1张金浩,耿建祥,樊志敏,徐文华,吴崑岚,陈建宁,赵雪,王小峰.肛管及肛门区尖锐湿疣组织中人乳头瘤病毒基因类型的研究[J].医学研究生学报,2011,24(11):1129-1132. 被引量:29
  • 2Bruni L,Diaz M,Castellsague X,et al.Cervical human papillomavirus prevalence in 5 continents:meta-analysis of I million women with normal cytological findings[J].J Infect Dis,2010,202(12):1789-99.
  • 3De Sanjose S,Quint W G,Alemany L,et al.Human papillomavirus genotype attribution in invasive cervical cancer:a retrospective cross-sectional worldwide study[J].Lancet Oncol,2010,11(11):1048-56.
  • 4Heymans J,Benoy I H,Poppe W,et al.Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation[J].Int J Cancer,2011,129(4):903-9.
  • 5Nomelini Rosekeila SimSes, Guimares Patrlcia Dias Neto, Candido Pamela Aparecida, Campos Ana Cldudia Camargo, Michelin Mdrcia Antoniazi, Murta Eddie Fernando Candido. Prevention of cervical cancer in women with ASCUS in the Brazilian Unified National Health System: ost-effectiven ess of the molecular biology method for HPV detection[J]. Cadernosde Saude Publica, 2012,28(ll):2043-2052.
  • 6Sarah Tinsley, Niloofar Nasseri-Nik, John Maksem. Creating a Visual Key as a Tool to Increase the Proportion of High-risk HPV (HRHPV) PositiveOutcomesamong ASCUS Cases Submitted for HCII Testing[J]. Journal of the American Society of Cytopathology, 2012,1(1):S31-S32.
  • 7Katki H A,Wentzensen N.How might HPV testing be integrated into cervical screening[J].Lancet Oncol,2012,13(1):8-10.
  • 8Clinton L K,Miyazaki K,Ayabe A,et al.The LAST guidelines in clinical practice: implementing recommendations for p16 use[J].Am J Clin Pathol,2015,144(6):844-849.
  • 9Thrall M J.Effect of lower anogenital squamous terminology recommenriations on the use of p!6 immunohistochemistry and the proportion of high-grade diagnoses in cervical biopsy specimens[J].Am J Clin Pathol,2016,145(4):524-530.
  • 10Miyamoto S,Hasegawa J,Morioka M,et al.The association between pl6 and Ki-67 imraunohistostaining and the progression of cervical intraepithelial neoplasia grade 2[J].Int J Gynaecol Obstet,2016,134(1 ):45-48.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部